Influenza B Virus Hemagglutinin vs Pembrolizumab

## Influenza B Virus Hemagglutinin vs Pembrolizumab: Overview

This comparison examines the pharmacological differences between **Influenza B Virus Hemagglutinin** and **Pembrolizumab**.

## Mechanism of Action

**Pembrolizumab**: Anti-PD-1 monoclonal antibody restoring anti-tumor immunity.

## Pharmacokinetics

**Half-life**: Influenza B Virus Hemagglutinin — N/A; Pembrolizumab — 26 days.

## Chemical Properties

**Type**: Influenza B Virus Hemagglutinin — Vaccine component; Pembrolizumab — Antibody.